LZAGY
Price
$70.26
Change
-$1.34 (-1.87%)
Updated
Jul 28 closing price
Capitalization
43.14B
84 days until earnings call
TMO
Price
$482.30
Change
-$2.66 (-0.55%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
220.19B
85 days until earnings call
Interact to see
Advertisement

LZAGY vs TMO

Header iconLZAGY vs TMO Comparison
Open Charts LZAGY vs TMOBanner chart's image
Lonza Group AG
Price$70.26
Change-$1.34 (-1.87%)
Volume$24.72K
Capitalization43.14B
Thermo Fisher Scientific
Price$482.30
Change-$2.66 (-0.55%)
Volume$15.74K
Capitalization220.19B
LZAGY vs TMO Comparison Chart in %
Loading...
LZAGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LZAGY vs. TMO commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LZAGY is a Hold and TMO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (LZAGY: $70.26 vs. TMO: $484.96)
Brand notoriety: LZAGY and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LZAGY: 34% vs. TMO: 122%
Market capitalization -- LZAGY: $43.14B vs. TMO: $220.19B
LZAGY [@Medical Specialties] is valued at $43.14B. TMO’s [@Medical Specialties] market capitalization is $220.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LZAGY’s FA Score shows that 1 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • LZAGY’s FA Score: 1 green, 4 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, LZAGY is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LZAGY’s TA Score shows that 3 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).

  • LZAGY’s TA Score: 3 bullish, 5 bearish.
  • TMO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TMO is a better buy in the short-term than LZAGY.

Price Growth

LZAGY (@Medical Specialties) experienced а +0.31% price change this week, while TMO (@Medical Specialties) price change was +19.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.45%. For the same industry, the average monthly price growth was +2.22%, and the average quarterly price growth was -4.55%.

Reported Earning Dates

LZAGY is expected to report earnings on Oct 21, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (-1.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($220B) has a higher market cap than LZAGY($43.1B). TMO has higher P/E ratio than LZAGY: TMO (37.38) vs LZAGY (32.68). LZAGY YTD gains are higher at: 21.209 vs. TMO (-6.604). TMO has higher annual earnings (EBITDA): 11.1B vs. LZAGY (1.42B). TMO has more cash in the bank: 8.08B vs. LZAGY (2.15B). LZAGY has less debt than TMO: LZAGY (2.91B) vs TMO (34.9B). TMO has higher revenues than LZAGY: TMO (42.9B) vs LZAGY (6.32B).
LZAGYTMOLZAGY / TMO
Capitalization43.1B220B20%
EBITDA1.42B11.1B13%
Gain YTD21.209-6.604-321%
P/E Ratio32.6837.3887%
Revenue6.32B42.9B15%
Total Cash2.15B8.08B27%
Total Debt2.91B34.9B8%
FUNDAMENTALS RATINGS
LZAGY vs TMO: Fundamental Ratings
LZAGY
TMO
OUTLOOK RATING
1..100
5676
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
6965
SMR RATING
1..100
9357
PRICE GROWTH RATING
1..100
5252
P/E GROWTH RATING
1..100
8281
SEASONALITY SCORE
1..100
506

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGY's Valuation (22) in the null industry is somewhat better than the same rating for TMO (65) in the Medical Specialties industry. This means that LZAGY’s stock grew somewhat faster than TMO’s over the last 12 months.

TMO's Profit vs Risk Rating (65) in the Medical Specialties industry is in the same range as LZAGY (69) in the null industry. This means that TMO’s stock grew similarly to LZAGY’s over the last 12 months.

TMO's SMR Rating (57) in the Medical Specialties industry is somewhat better than the same rating for LZAGY (93) in the null industry. This means that TMO’s stock grew somewhat faster than LZAGY’s over the last 12 months.

TMO's Price Growth Rating (52) in the Medical Specialties industry is in the same range as LZAGY (52) in the null industry. This means that TMO’s stock grew similarly to LZAGY’s over the last 12 months.

TMO's P/E Growth Rating (81) in the Medical Specialties industry is in the same range as LZAGY (82) in the null industry. This means that TMO’s stock grew similarly to LZAGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LZAGYTMO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 7 days ago
56%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 15 days ago
55%
Bearish Trend 14 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
LZAGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACCO4.00N/A
N/A
Acco Brands Corp
MMLP2.80N/A
N/A
Martin Midstream Partners LP
GFL48.13-0.09
-0.19%
GFL Environmental
EVOK4.36-0.07
-1.58%
Evoke Pharma, Inc.
IBRX2.65-0.21
-7.34%
ImmunityBio